Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-02Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-14Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-03-28Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortexTranslational Psychiatry · 2025-03-24LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in MicePharmaceuticals · 2025-03-22Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-02-12Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.Unknown journal · 2025-01-31The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.Unknown journal · 2024-11-05Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility studyPhilosophical Transactions of the Royal Society B Biological Sciences · 2024-10-20Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorderPsychedelics. · 2024-09-23The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodentsbioRxiv · 2024-04-21Psychedelic Therapy: A Primer for Primary Care Clinicians-PsilocybinAmerican Journal of Therapeutics · 2024-02-29Psilocybin induces dose-dependent changes in functional network organization in rat cortexbioRxiv · 2024-02-11Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative studyScientific Reports · 2024-02-04Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Unknown journal · 2024-01-10Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2023-12-31347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic DisorderBiological Psychiatry · 2023-04-09Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorderJournal of Psychiatric Research · 2023-03-27The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in MiceMolecules · 2023-03-13Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2022-12-31Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatednessJournal of Psychopharmacology · 2022-12-31Psychedelics, epilepsy, and seizures: a review.Frontiers in pharmacology · 2022-12-31Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-29Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.Drug Testing and Analysis · 2022-05-28Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PLoS ONE · 2022-03-15Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.Unknown journal · 2022-01-12The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31A systematic literature review of clinical trials and therapeutic applications of ibogaine.Unknown journal · 2021-12-29P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-11-30Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-19Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.European Neuropsychopharmacology · 2021-07-07New insights into the clinical and nonclinical effects of psychedelic substances: an integrative reviewPsyArXiv · 2021-05-04Have Norwegians tried psilocybin, and do they accept it as a medicine?Journal of Psychedelic Studies · 2021-04-15Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.Journal of Natural Products · 2021-03-04Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experiencebioRxiv · 2021-02-04Investigation of the Structure-Activity Relationships of Psilocybin AnaloguesACS Pharmacology & Translational Science · 2020-12-13P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experienceEuropean Neuropsychopharmacology · 2020-10-31Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.Neuropharmacology · 2020-04-30DARK Classics in Chemical Neuroscience: NBOMes.Unknown journal · 2019-11-11Hallucinogens and Their Therapeutic Use: A Literature Review.Unknown journal · 2019-08-31Second and third year medical students' self-reported alcohol and substance use, smoking habits and academic performance at a South African medical school.Health SA = SA Gesondheid · 2018-12-31DARK Classics in Chemical Neuroscience: Psilocybin.Unknown journal · 2018-07-15Effect of Hallucinogens on Unconditioned Behavior.Current topics in behavioral neurosciences · 2017-12-31Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness.Journal of Psychopharmacology · 2017-06-19Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.Unknown journal · 2014-07-14Serotonergic hallucinogens as translational models relevant to schizophrenia.Unknown journal · 2013-08-12Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.Experimental Brain Research · 2013-06-01Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.Unknown journal · 2011-01-19Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.Journal of Psychopharmacology · 2010-12-07Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.Archives of General Psychiatry · 2010-09-05Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in miceRevista Brasileira de Farmacognosia · 2010-06-30Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology · 2008-05-17Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.Journal of Psychopharmacology · 2007-04-30Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.Pharmacopsychiatry · 2005-10-31Detection of psilocin in body fluids.Unknown journal · 2000-08-31529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humansInternational Journal of Psychophysiology · 1998-08-31A novel extraction procedure for psilocybin and psilocin determination in mushroom samples.Unknown journal · 1990-05-31Psilocybin in Fruchtkörpern vonInocybe aeruginascensPlanta Medica · 1986-03-31Psilocybin intoxication.Unknown journal · 1980-08-31ANALOGUES OF PSILOCIN AND LYSERGIC ACID DIETHYLAMIDE I. CHLORO, NITRO, AND AMINO DERIVATIVES OF3-SUBSTITUTED INDOLESCanadian Journal of Chemistry · 1963-09-30